Human immunodeficiency virus in Uzbekistan: Epidemiological and genetic analyses

AIDS Research and Human Retroviruses

Volumn 19, Issue 9, 2003, Pages 731-738

  Kurbanov, Fuat ^a,b   Mizokami, Masashi ^a   Imai, Mitsunobu ^c   Kondo, Makiko ^c   Tanaka, Yasuhito ^a   Zalalieva, Mariam ^b,d   Giasova, Guzal ^d   Shima, Takako ^c   Jounai, Nao ^c   Yuldasheva, Nadira ^b   Ruzibakiev, Ruslan ^b  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b S YU YUNUSOV INSTITUTE OF THE CHEMISTRY OF PLANT SUBSTANCES   (Uzbekistan)

^c KANAGAWA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^d Ministry of Public Health   (Uzbekistan)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DRUG ABUSE; DRUG ADMINISTRATION ROUTE; ENVELOPE GENE; EPIDEMIOLOGICAL DATA; FEMALE; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MICROBIAL POPULATION DYNAMICS; MOLECULAR DYNAMICS; MOLECULAR PHYLOGENY; NUCLEOTIDE SEQUENCE; POPULATION RESEARCH; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SEROPREVALENCE; UZBEKISTAN; VIRUS ISOLATION; VIRUS STRAIN; VIRUS TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; BASE SEQUENCE; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS B; HEPATITIS C; HIV-1; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; SUBSTANCE ABUSE, INTRAVENOUS; SYPHILIS; UZBEKISTAN;

EID: 0141593494     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922203769232520     Document Type: Article

References (32)

1. UNAIDS/WHO: AIDS Epidemic Update: December 2001. (www.unaids.org)
2. Ruzibakiev R, Kato H, Ueda R, et al.: Risk factors and seroprevalence of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection in Uzbekistan. Intervirology 2001;44:327-332.
3. Galo R, Salahuddin SZ, Popovic M, et al.: Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 1984;224:500-503.
4. Loussert-Ajaka I, Chaix M-L, Korber B, et al.: Variability of human immunodeficiency virus type 1 group O strain from Cameroon patients living in France. J Virol 1995;69:5640-5649.
5. Simon F, Mauclere P, Roques P, et al.: Identification of a new human immunodeficiency virus type 1 distinct from group M and group O. Nat Med 1998;4:1032-1037.
6. Zhu T, Korber BT, Nahmias AJ, et al.: An African HIV-1 sequence from 1959 and implications for the origin of the epidemic. Nature 1998;391:594-597.
7. Leitner T and Albert J: The molecular clock of HIV-1 unveiled through analysis of a known transmission history. Proc Natl Acad Sci USA 1999;96:10752-10757.
8. Francis DP, Gregory T, McElarth MJ, et al.: Advancing AIDSVAX to phase 3: Safety, immunogenicity, and plans for phase 3. AIDS Res Hum Retroviruses 1998;14:325-331.
9. Korber B, Theiler J, and Wolinsky S: Limitations of a molecular clock applied to considerations of the origin of HIV-1. Science 1998;280:1868-1871.
10. Lukashov VV, Cornelissen MTE, Goudsmit J, et al.: Simultaneous introduction of distinct HIV-1 subtypes into different risk groups in Russia, Belorussia and Lithuania. AIDS 1995;9:435-439.
11. Bobkov A, Cheingsong-Popov R, Selimova L, et al.: An HIV type 1 epidemic among injecting drug users in the former Soviet Union caused by a homogeneous subtype A strain. AIDS Res Hum Retroviruses 1997;13:1195-1201.
12. Bobkov A, Kazennova E, Selimova L, et al.: A sudden epidemic of HIV type 1 among injecting drug users in the former Soviet Union: Identification of subtype A, subtype B, and novel gagA/envB recombinants. AIDS Res Hum Retroviruses 1998;4:669-676.
13. Ohno T, Mizokami M, Wu RR, et al.: New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a. J Clin Microbiol 1997;35:201-207.
14. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, and Higgins DG: The CLUSTAL_X Windows interface: Flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 1997;25:4876-4882.
15. Gojobori T, Ishii K, and Nei M: Estimation of average number of nucleotide substitutions when the rate of substitutions varies. J Mol Evol 1982;28:414-423.
16. Saitou N and Nei M: The neighbor-joining method: A new method for reconstructing phylogenetic trees. Mol Biol Evol 1987;4:406-425.
17. Pybus OG and Rambaut A: GENIE: Estimating demographic history from molecular phylogenies. Bioinformatics 2002;18:1404-1405.
18. Pybus OG, Charleston A, Gupta S, Rambaut A, Holmes EC, and Harvey PH: The epidemic behavior of the hepatitis C virus. Science 2001;292:2323-2325.
19. Tanaka Y, Hanada K, Mizokami M, et al.: A comparison of molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the US will increase over the next two decades. Proc Natl Acad Sci USA 2002;99:15584-15589.
20. Salter LA and Pearl DK: Stochastic search strategy for estimation of maximum likelihood phylogenetic trees. Syst Biol 2001;50:7-17.
21. Pybus OG, Rambaut A, and Harvey P: An integrated framework for the inference of viral population history from reconstructed genealogies. Genetics 2000;155:1429-1437.
22. Strimmer K and Pybus OG: Exploring the demographic history of DNA sequences using the generalized skyline plot. Mol Biol Evol 2001;18:2298-2305.
23. Liitsola K, Tashkinova I, Laukkanen T, et al.: HIV-1 genetic subtype A/B recombinant starin causing an explosive epidemic in injecting drug users in Kaliningrad. AIDS 1998;14:1907-1919.
24. Sccherbinskaia A, Kobyshcha I, Kruglov I, et al.: The epidemic situation in relation to HIV infection in Ukraine (1987-1997) [in Russian]. Zh Mikrobiol Epidemiol Immunobiol 1999;1:26-29.
25. Kuiken C, Thakallapalli R, Esklid A, and de Ronde A: Genetic analysis reveals epidemiologic patterns in the spread of human immunodeficiency virus. Am J Epidemiol 2000;152:814-822.
26. Novitsky VA, Montano M, and Essex M: A subcluster among injecting drug users in the former Soviet Union caused by homogeneous subtype A strain. AIDS Res Hum Retroviruses 1998;13:1195-1201.
27. Lukashev V, Huismans R, Rakhmanova A, et al.: Circulation of subtype A and gagA/envB recombinant HIV type 1 strains among injecting drug users in St. Petersburg, Russia, correlates with geographical origin of infections. AIDS Res Hum Retroviruses 1999;15:1577-1583.
28. Nabatov A, Kravchenko O, Lyulchuk M, Shcherbinskaya A, and Lukashev V: Simultaneous introduction of HIV type 1 subtype A and B viruses into injecting drug users in southern Ukraine at the beginning of the epidemic in the former Soviet Union. AIDS Res Hum Retroviruses 2002;18:891-895.
29. International Labour Organization: ILO Subregional Tripartite Seminar on HIV/AIDS Pandemic - Social Consequences in the CIS Countries, Moscow, December 10-12, 2002 (www.ilo.ru/aids/dec02.htm).
30. Zhang C, Yang R, Xia X, et al.: High prevalence of HIV-1 and hepatitis C coinfection among injection drug users in the southeastern region of Yunnan, China. AIDS 2002;29:191-196.
31. Kurbanov F, Tanaka Y, Sugauchi F, et al.: Hepatitis C molecular epidemiology in Uzbekistan. J Med Virol. 2003;69:367-375.
32. Bobkova MR, Samokhvalov EI, Kravchenko AV, et al.: Genetic variants of hepatitis C virus in HIV-infected drug users [in Russian]. Vopr Virusol 2002;47:15-20.